Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat

被引:39
作者
Chung, JG [1 ]
机构
[1] China Med Coll, Dept Med, Taichung 400, Taiwan
关键词
butylated hydroxyanisole (BHA); butylated hydroxytoluene (BHT); N-acetyltransferase (NAT) activity; arylamine toxicity; rats;
D O I
10.1093/toxsci/51.2.202
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The effects of the synthetic phenolic antioxidants (butylated hydroxyanisole and butylated hydroxytoluene) on the in vivo acetylation of 2-aminofluorene and formation of DNA-2-aminofluorene adducts were investigated in male Sprague-Dawley rats. For in vitro examination, cytosols and intact cells, with or without butylated hydroxyanisole and butylated hydroxytoluene co-treatment, showed different percentages of 2-aminofluorene acetylation and DNA-2-aminofluorene adducts. For in vivo examination, pretreatment of male rats with butylated hydroxyanisole and butylated hydroxytoluene (10 mg/kg) 48 h prior to the administration of 2-aminofluorene (50 mg/kg) resulted in 34% and 18%, 29% and 20% decreases, respectively, in the urinary and fecal recovery of N-acetyl-2-aminofluorene, and 34% and 19% decreases, respectively, in the metabolic clearance of 2-aminofluorene to N-acetyl-2-aminofluorene. Following exposure of rats to the 2-aminofluorene, with or without pretreatment with butylated hydroxyanisole and butylated hydroxytoluene, DNA-2-aminofluorene adducts were observed in the target tissues of liver and bladder, and also in circulating leukocytes. The DNA-2-aminofluorene adducts in liver, bladder, and leukocytes were decreased by pretreatment with butylated hydroxyanisole and butylated hydroxytoluene. This is the first demonstration that synthetic phenolic antioxidants decrease the N-acetylation of carcinogens and formation of DNA-carcinogen adducts in vivo.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 41 条
[1]  
AUNE T, 1985, CANCER RES, V45, P5859
[2]  
BENSON AM, 1984, CANCER RES, V44, P5256
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
CHIPMAN JK, 1988, MUTAT RES, V207, P193, DOI 10.1016/0165-7992(88)90086-3
[5]  
CHUNG JG, 1993, DRUG METAB DISPOS, V21, P1057
[6]  
CHUNG JG, 1999, IN PRESS J APPL TOXI
[7]  
DUSOUICH P, 1981, DRUG METAB DISPOS, V9, P279
[8]   MUTAGENICITY OF 30 CHEMICALS IN SALMONELLA-TYPHIMURIUM STRAINS POSSESSING DIFFERENT NITROREDUCTASE OR O-ACETYLTRANSFERASE ACTIVITIES [J].
EINISTO, P ;
WATANABE, M ;
ISHIDATE, M ;
NOHMI, T .
MUTATION RESEARCH, 1991, 259 (01) :95-102
[9]   ENHANCEMENT BY BUTYLATED HYDROXYTOLUENE OF THE INVITRO ACTIVATION OF 3,3'-DICHLOROBENZIDINE [J].
GHOSAL, A ;
IBA, MM .
MUTATION RESEARCH, 1992, 278 (01) :31-41
[10]  
GRANT DM, 1992, CANCER RES, V52, P3961